Initial Therapeutics

Biotechnology company creating novel drugs that prevent the formation of difficult-to-drug proteins, targeting protein homeostasis with a cotranslational degradation approach.

Location
Cambridge, Massachusetts, USA
Founded
2021
Investors
1
Categories
biotech, drug-discovery, protein-homeostasis, undruggable-targets

Investors

NameLocationTypeStagesPortfolio
Apple Tree PartnersNew York, USAbiotech-focused
series-aseries-b+2
23